35 results
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
23 Jan 24
Current report (foreign)
6:49am
of Business Development and Strategy for Perrigo. Mr. Kochan was Vice President, Business Development of Agis Industries (1983) Ltd. ("Agis") from 2001 until
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
30 Nov 23
Current report (foreign)
7:10am
the preventive effect of the medication. Other insights that we are using in our Phase 3 trial design strategy are to pre-screen patients for a specific
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
21 Jun 23
Notice of Annual Meeting of Shareholders
9:38am
and strategy committees at Bank Leumi, and a board member and member of the audit committee and compensation committee of VBL Therapeutics and a Board … Pharmaceuticals Industries Ltd., including Vice President of Finance and Vice President of Strategy. From 2000 to 2004, Dr. Ben Zvi was the financial advisor
6-K
EX-99.1
d6d w74edv96zzs
6 Jun 23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to
7:15am
6-K/A
EX-99.1
awk8kkyh dkf
23 May 22
Notice of Annual Meeting of Shareholders
4:05pm
6-K
EX-99.1
wfsu96xgtj
19 May 22
Notice of Annual Meeting of Shareholders
4:30pm
424B5
yxxmychyztef
19 Apr 22
Prospectus supplement for primary offering
4:02pm
6-K
EX-99.1
pro8mfs4s x80w
14 Apr 22
Notice of Annual Meeting of Shareholders
4:45pm
20-F/A
m6bcgsco
7 Apr 22
Annual report (foreign) (amended)
4:06pm
6-K
EX-99.2
w4o2gyw66733i 3c
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am
6-K
EX-99.1
fxvmbbhps7f0s3no k8
1 Jun 21
Notice of Annual Meeting of Shareholders
2:02pm
6-K
EX-99.1
ketc4ob886i 77
18 Feb 21
Current report (foreign)
1:20pm
6-K
EX-99.1
vf4e30gt384
12 Nov 20
Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update
9:07am
6-K
EX-99.1
hnedit91wx c3oeqozu
6 Aug 20
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update
10:37am